Clinical Trial

Rehabilitation of People With Post-tuberculosis Lung Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 13, 2023 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Tuberculosis (TB) can leave numerous sequelae, where survivors experience a transition from an acute illness to living with a multifaceted chronic illness. Post-TB lung disease (PD-PTB) encompasses lung diseases and pathologies that occur after one or more episodes of TB, which can affect the patient's lung health and cause disabling symptoms that strongly affect their long-term health. In 2020, it was estimated that there were 155 million TB survivors still alive worldwide, with a large proportion of them carrying functional sequelae with profound socioeconomic repercussions. Thus, the aim of this study is to evaluate the effect of pulmonary rehabilitation (PR) on functionality and health-related quality of life (HRQoL) of people with PD-PTB and to build a PD-PTB severity scoring system based on the data. of pre-RP individuals using artificial intelligence technique.
Trial Details
NCT Number NCT06127641
Lead Sponsor Centro Universitário Augusto Motta
Collaborators: Rio de Janeiro State University
Conditions Pulmonary Tuberculosis
Enrollment 40 participants
Start Date 2023-10-28
Primary Completion 2024-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-11-13